Skip to main content
. 2017 Apr 26;9(5):428. doi: 10.3390/nu9050428

Table 2.

Value changes at 12 months of treatment. Data are expressed as mean ± standard error.

Characteristic Denosumab (n = 22) Combination (n = 21) p-Value
L-BMD (g/cm2) 0.74 ± 0.03 0.72 ± 0.04 0.6983
H-BMD (g/cm2) 0.49 ± 0.02 0.54 ± 0.03 0.2236
MMP-3 (ng/mL) 68.6 ± 9.6 56.0 ± 8.6 0.3518
DAS28-CRP 2.7 ± 0.3 2.0 ± 0.3 0.0793
SDAI 4.6 ± 1.1 4.7 ± 1.4 0.9327
HAQ-DI 0.38 ± 0.2 0.28 ± 0.1 0.6359